Previous close | 16.00 |
Open | 25.00 |
Bid | 13.40 |
Ask | 20.60 |
Strike | 460.00 |
Expiry date | 2024-01-19 |
Day's range | 16.00 - 25.00 |
Contract range | N/A |
Volume | |
Open interest | 99 |
Thermo Fisher's (TMO) new cell therapy facility at UCSF is likely to accelerate the development of advanced therapies.
Over the past year, many Thermo Fisher Scientific Inc. ( NYSE:TMO ) insiders sold a significant stake in the company...
Berkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and Synopsys are included in this Analyst Blog.